ANNA MATTHEWS: Open Payments
NPI 1972095206 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $275 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $173 |
| HEARTFLOW, INC. | 3 | $157 |
| BridgeBio Pharma, Inc. | 3 | $87 |
| ABIOMED | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| GENZYME CORPORATION | 1 | $32 |
| SCPHARMACEUTICALS INC. | 2 | $28 |
| Inari Medical, Inc. | 1 | $20 |
Products named: FFRct, WAINUA, Attruby, Kerendia, CAMZYOS, LEQVIO, FABRAZYME, FUROSCIX.
Industry payments across CO — which companies pay providers there.
